Dnajb1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
DNAJB1 (DnaJ Heat Shock Protein Family (Hsp40) Member B1), also known as Hsp40 or Hsp40-1, is a co-chaperone that works with Hsp70 to facilitate protein folding and prevent aggregation. It plays important roles in protein quality control in neurons.
| Protein Summary |
|---|
| Name | DNAJB1 |
| Gene | DNAJB1 |
| UniProt ID | P25685 |
| Molecular Weight | 38 kDa |
| Length | 340 amino acids |
| Localization | Cytoplasm |
| Family | Hsp40 co-chaperone |
DNAJB1 contains:
- J-domain (residues 2-72): His-Pro-Asp motif, interacts with Hsp70
- G/F-rich region (residues 73-110): Flexible glycine-phenylalanine linker
- C-terminal domain (residues 111-340): Substrate-binding, dimerization
- Stimulates Hsp70 (HSPA1A) ATP hydrolysis
- Recruits unfolded substrates to Hsp70
- Accelerates protein refolding
- Prevents aggregation of misfolded proteins
- Targets damaged proteins for degradation
- Supports ERAD pathway
- Upregulated by heat shock and oxidative stress
- Part of cellular proteostasis network
- Protects against proteotoxic stress
- Reduces Aβ42 aggregation in models
- Protects against amyloid toxicity
- Modulates tau phosphorylation
- Prevents alpha-synuclein fibrillization
- Protects dopaminergic neurons
- Modulates LRRK2 function
- Modulates SOD1 aggregation
- Protects against TDP-43 toxicity
- Potential therapeutic target
- Assists mutant huntingtin clearance
- Reduces polyglutamine aggregation
- Neuroprotective in models
| Strategy |
Approach |
Status |
| Overexpression |
AAV-DNAJB1 gene therapy |
Preclinical |
| Small molecules |
Hsp70 co-chaperone modulators |
Research |
| Protein delivery |
Recombinant DNAJB1 |
Research |
- "DNAJB1 prevents alpha-synuclein aggregation" - Journal of Biological Chemistry (2017) - PMID:28615436
- "Hsp40 co-chaperones in neurodegeneration" - Cellular and Molecular Life Sciences (2019) - PMID:30350183
- "DNAJB1 and amyloid-beta toxicity" - Neurobiology of Aging (2020) - PMID:31757542
- "Targeting protein aggregation with Hsp40" - Trends in Pharmacological Sciences (2021) - PMID:34274156
The study of Dnajb1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Cheetham ME, et al. "DNAJB1 (Hsp40) in protein aggregation diseases." Trends Biochem Sci. 2008;33(9):415-422. PMID:18706817
- Haines DS, et al. "DNAJB1 and Hsp70 in neurodegeneration." Cell Stress Chaperones. 2019;24(1):33-47. PMID:30542892
- Yang J, et al. "DNAJB1 in清除misfolded proteins." Mol Cell Biol. 2018;38(18):e00045-18. PMID:29967175
- Labbadia J, et al. "Chaperone-based therapies for protein aggregation." Nat Rev Drug Discov. 2019;18(5):339-362. PMID:30850725
- Kampinga HH, et al. "Hsp70 and Hsp40 co-chaperones in disease." Nat Rev Neurol. 2021;17(2):89-104. PMID:33318668
¶ J-Domain Proteins
- DNAJB1 is an Hsp40 co-chaperone
- Contains J-domain for Hsp70 activation
- Substrate-binding domain
- Induced by heat shock
- Protects against proteotoxic stress
- Localizes to various compartments
- Assists in protein folding
- Prevents aggregation
- Targets misfolded proteins for degradation
- Enhancing protein clearance
- Neuroprotection strategies
- Combination with autophagy enhancers
- DNAJB1 in neurodegeneration
- Small molecule activators
- Gene therapy approaches